Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Current Liabilities
All obligations due within one year.
Microbot Medical Inc.NASDAQ: MBOT
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 78.9% from a year ago
Total current liabilities stood at $3.39M at the end of Q1 FY2026, up 78.9% from a year earlier and down 1.0% from the prior quarter. Over 3 fiscal years it compounded at +18.2% a year.
Context
- Total current liabilities amounted to 4.3% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +78.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 3.42M USD
- Year-over-year change
- +39.1%
- 4-year CAGR
- +14.6%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.42M | +39.1% |
| FY2024 | 2024-12-31 | 2.46M | -35.0% |
| FY2023 | 2023-12-31 | 3.79M | +83.0% |
| FY2022 | 2022-12-31 | 2.07M | +4.3% |
| FY2021 | 2021-12-31 | 1.98M | — |
Total Current Liabilities vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +78.9% is the 4th highest of 10, against a peer median of +9.3%.
- Total current liabilities amounts to 4.3% of total assets for MBOT, versus a peer median of 22.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $77.22M USD | -28.2% | -12.3% | 36.9% | |
| Mar 2026 | $66.67M USD | +190.4% | +80.3% | 129.3% | |
| Mar 2026 | $15.75M USD | +69.2% | +5.8% | 7.0% | |
| Mar 2026 | $10.56M USD | +92.3% | +49.2% | 3.9% | |
| Mar 2026 | CA$7.15M CAD | -7.8% | -7.9% | 22.7% | |
| Mar 2026 | $6.78M USD | +9.3% | -1.1% | 16.0% | |
| Mar 2026 | $6.73M USD | -37.5% | -8.0% | 31.1% | |
| Mar 2026 | $6.53M USD | +243.9% | +35.7% | 11.1% | |
| Mar 2026 | CA$3.54M CAD | +1.7% | +13.5% | 23.4% | |
| Mar 2026 | $3.39M USD | +78.9% | +18.2% | 4.3% | |
| Peer median (excluding MBOT) | — | +9.3% | +5.8% | 22.7% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.